UK markets closed

Sanara MedTech Inc. (SMTI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
33.37-0.13 (-0.39%)
As of 12:26PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 288.86M
Enterprise value 295.51M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.27
Price/book (mrq)6.44
Enterprise value/revenue 4.55
Enterprise value/EBITDA -1.02k

Trading information

Stock price history

Beta (5Y monthly) 1.63
52-week change 3-12.07%
S&P500 52-week change 325.38%
52-week high 346.40
52-week low 326.06
50-day moving average 334.98
200-day moving average 335.37

Share statistics

Avg vol (3-month) 312.95k
Avg vol (10-day) 311.35k
Shares outstanding 58.62M
Implied shares outstanding 68.62M
Float 83.45M
% held by insiders 160.07%
% held by institutions 18.39%
Shares short (15 Apr 2024) 4140.25k
Short ratio (15 Apr 2024) 410.09
Short % of float (15 Apr 2024) 425.91%
Short % of shares outstanding (15 Apr 2024) 41.63%
Shares short (prior month 15 Mar 2024) 4144.04k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 310 May 2019
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 310 May 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -6.62%
Operating margin (ttm)-12.33%

Management effectiveness

Return on assets (ttm)-7.10%
Return on equity (ttm)-10.29%

Income statement

Revenue (ttm)64.99M
Revenue per share (ttm)7.85
Quarterly revenue growth (yoy)15.50%
Gross profit (ttm)N/A
EBITDA -3.99M
Net income avi to common (ttm)-4.3M
Diluted EPS (ttm)-0.52
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.15M
Total cash per share (mrq)0.6
Total debt (mrq)11.79M
Total debt/equity (mrq)26.45%
Current ratio (mrq)1.38
Book value per share (mrq)5.25

Cash flow statement

Operating cash flow (ttm)-3.25M
Levered free cash flow (ttm)-97.56k